+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cisplatin"

Ipilimumab + nivolumab Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Ipilimumab + nivolumab Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
Metastatic Urothelial Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Urothelial Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 150 Pages
  • Global
From
Extensive-Stage Small Cell Lung Cancer (ESCLC) - Pipeline Insight, 2024 - Product Thumbnail Image

Extensive-Stage Small Cell Lung Cancer (ESCLC) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
US Glioma - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

US Glioma - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • April 2023
  • 200 Pages
  • United States
From
Gemcitabine HCL Market Report and Forecast 2023-2031 - Product Thumbnail Image

Gemcitabine HCL Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
From
From
Skin Cancer Treatment Drugs Markets in China - Product Thumbnail Image

Skin Cancer Treatment Drugs Markets in China

  • Report
  • September 2024
  • 231 Pages
  • China
From
Skin Cancer Treatment Drugs Companies in China - Product Thumbnail Image

Skin Cancer Treatment Drugs Companies in China

  • Report
  • September 2024
  • 74 Pages
  • China
From
Skin Cancer Treatment Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Skin Cancer Treatment Drugs Industry Forecasts - China Focus

  • Report
  • September 2024
  • 103 Pages
  • China
From
Loading Indicator

Cisplatin is a chemotherapy drug used to treat a variety of cancers, including lung cancer. It works by damaging the DNA of cancer cells, preventing them from growing and dividing. Cisplatin is often used in combination with other drugs to increase its effectiveness. It is administered intravenously and can cause side effects such as nausea, vomiting, and hair loss. The market for cisplatin in the treatment of lung cancer is highly competitive, with many companies offering their own versions of the drug. Companies such as Bristol-Myers Squibb, Pfizer, and Merck & Co. are all major players in the market. Other companies, such as Teva Pharmaceuticals and Mylan, also offer generic versions of the drug. In the market for cisplatin, companies such as Bristol-Myers Squibb, Pfizer, Merck & Co., Teva Pharmaceuticals, and Mylan are all major players. Show Less Read more